Mersana Therapeutics
Price & Volume
Stats
See more52W Range | $0.49-$6.28 |
Market Cap | $65.2M |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $34.8M |
Revenue Growth (YoY) | 63.7% |
Gross Profit (12 Mos) | -$37.3M |
Diluted EPS | -$0.60 |
News
See moreYahoo Finance • 15 days ago
Mersana Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 24 days ago
Mersana Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference
Yahoo Finance • last year
15 Small-Cap Stocks with High Potential
Yahoo Finance • last year
Mersana Therapeutics Inc (MRSN) Reports Q3 2023 Financial Results
About
CEO | Dr. Martin H. Huber M.D. |
CFO | Mr. Brian C. DeSchuytner |
Address | 840 Memorial Drive, Cambridge, MA, United States, 02139 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 123 |
